Skip to main navigation
Skip to search
Skip to main content
University of Edinburgh Research Explorer Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Datasets
Prizes
Activities
Press/Media
Equipment
Search by expertise, name or affiliation
Stem cell therapy for liver cirrhosis
Forbes, Stuart
(Principal Investigator)
Deanery of Clinical Sciences
Overview
Fingerprint
Research output
(1)
Project Details
Status
Finished
Effective start/end date
1/10/07
→
30/09/15
Funding
UK-based charities:
£1,270,321.00
View all
View less
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Galectin 3
Medicine & Life Sciences
100%
Hepatocytes
Medicine & Life Sciences
63%
Stem Cells
Medicine & Life Sciences
55%
Liver
Medicine & Life Sciences
39%
Wounds and Injuries
Medicine & Life Sciences
36%
Laminin
Medicine & Life Sciences
22%
3,5-diethoxycarbonyl-1,4-dihydrocollidine
Medicine & Life Sciences
9%
Galactosides
Medicine & Life Sciences
7%
Research output
Research output per year
2015
2015
2015
1
Article
Research output per year
Research output per year
Galectin-3 regulates hepatic progenitor cell expansion during liver injury
Hsieh, W-C.
,
Mackinnon, A. C.
,
Lu, W-Y.
,
Jung, J.
,
Boulter, L.
,
Henderson, N. C.
,
Simpson, K. J.
,
Schotanus, B.
,
Wojtacha, D.
,
Bird, T. G.
,
Medine, C. N.
,
Hay, D. C.
,
Sethi, T.
,
Iredale, J. P.
&
Forbes, S. J.
,
Feb 2015
,
In:
Gut.
64
,
2
,
p. 312-321
10 p.
Research output
:
Contribution to journal
›
Article
›
peer-review
Galectin 3
100%
Hepatocytes
63%
Stem Cells
55%
Liver
39%
Wounds and Injuries
36%